BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Panés J, Alfaro I. New treatment strategies for ulcerative colitis. Expert Rev Clin Immunol 2017;13:963-73. [PMID: 28617055 DOI: 10.1080/1744666X.2017.1343668] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Hassan SMA, Hassan AH. Effect of Shogaol on the Expression of Intestinal Stem Cell Markers in Experimentally Induced Colitis in BALB/c Mice. Anal Cell Pathol (Amst) 2019;2019:5134156. [PMID: 30963020 DOI: 10.1155/2019/5134156] [Reference Citation Analysis]
2 Kaur G, Singh SK, Kumar R, Kumar B, Kumari Y, Gulati M, Pandey NK, Gowthamarajan K, Ghosh D, Clarisse A, Wadhwa S, Mehta M, Satija S, Dua K, Dureja H, Gupta S, Singh PK, Kapoor B, Chitranshi N, Kumar A, Porwal O. Development of modified apple polysaccharide capped silver nanoparticles loaded with mesalamine for effective treatment of ulcerative colitis. Journal of Drug Delivery Science and Technology 2020;60:101980. [DOI: 10.1016/j.jddst.2020.101980] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
3 Zhao J, Zhang B, Mao Q, Ping K, Zhang P, Lin F, Liu D, Feng Y, Sun M, Zhang Y, Li QH, Zhang T, Mou Y, Wang S. Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5-ASA-PABA-MAC and 5-ASA-PABA-Diamine for the Treatment of Ulcerative Colitis. J Med Chem 2022. [PMID: 35275619 DOI: 10.1021/acs.jmedchem.1c02166] [Reference Citation Analysis]
4 Luo L, Qing L, Yao C, Liu D, Li Y, Li T, Feng P. Efficacy and safety of hyperbaric oxygen therapy for moderate-to-severe ulcerative colitis: a protocol for a systematic review and meta-analysis. BMJ Open 2021;11:e047543. [PMID: 34183344 DOI: 10.1136/bmjopen-2020-047543] [Reference Citation Analysis]
5 Weisel K, Scott N, Berger S, Wang S, Brown K, Powell M, Broer M, Watts C, Tompson DJ, Burriss SW, Hawkins S, Abbott-Banner K, Tak PP. A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis. BMJ Open Gastroenterol 2021;8:e000680. [PMID: 34389633 DOI: 10.1136/bmjgast-2021-000680] [Reference Citation Analysis]
6 Zou J, Shen Y, Chen M, Zhang Z, Xiao S, Liu C, Wan Y, Yang L, Jiang S, Shang E, Qian D, Duan J. Lizhong decoction ameliorates ulcerative colitis in mice via modulating gut microbiota and its metabolites. Appl Microbiol Biotechnol. 2020;104:5999-6012. [PMID: 32418127 DOI: 10.1007/s00253-020-10665-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
7 da Silva LM, de Souza P, Jaouni SKA, Harakeh S, Golbabapour S, de Andrade SF. Propolis and Its Potential to Treat Gastrointestinal Disorders. Evid Based Complement Alternat Med 2018;2018:2035820. [PMID: 29736177 DOI: 10.1155/2018/2035820] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
8 Deng J, Wu Z, Zhao Z, Wu C, Yuan M, Su Z, Wang Y, Wang Z. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis. Int J Nanomedicine 2020;15:3937-51. [PMID: 32581538 DOI: 10.2147/IJN.S247406] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
9 Faramarzpour A, Tehrani AA, Tamaddonfard E, Imani M. The effects of crocin, mesalazine and their combination in the acetic acid-induced colitis in rats. Vet Res Forum 2019;10:227-34. [PMID: 31737232 DOI: 10.30466/vrf.2019.35900] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Shi B, Liu S, Huang A, Zhou M, Sun B, Cao H, Shan J, Sun B, Lin J. Revealing the Mechanism of Friedelin in the Treatment of Ulcerative Colitis Based on Network Pharmacology and Experimental Verification. Evid Based Complement Alternat Med 2021;2021:4451779. [PMID: 34765000 DOI: 10.1155/2021/4451779] [Reference Citation Analysis]
11 Lu A, Tao L, Li Q, Zhang J, Tang M, Yu W, Wang Y, Ai Z, Zhao Y, Liu H, Wu X. The rationale for using Periplaneta americana as a monarch drug of TCM in the treatment of damp-heat ulcerative colitis. Informatics in Medicine Unlocked 2021;26:100746. [DOI: 10.1016/j.imu.2021.100746] [Reference Citation Analysis]
12 Annese V. An update on treatment of ulcerative colitis. Expert Opinion on Orphan Drugs 2019;7:295-304. [DOI: 10.1080/21678707.2019.1638249] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Yang B, Li M, Wang S, Ross RP, Stanton C, Zhao J, Zhang H, Chen W. Lactobacillus ruminis Alleviates DSS-Induced Colitis by Inflammatory Cytokines and Gut Microbiota Modulation. Foods 2021;10:1349. [PMID: 34208038 DOI: 10.3390/foods10061349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Pérez-Jeldres T, Tyler CJ, Boyer JD, Karuppuchamy T, Yarur A, Giles DA, Yeasmin S, Lundborg L, Sandborn WJ, Patel DR, Rivera-Nieves J. Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists. Front Pharmacol 2019;10:212. [PMID: 30930775 DOI: 10.3389/fphar.2019.00212] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 13.7] [Reference Citation Analysis]
15 Feng Z, Zhou P, Wu X, Zhang J, Zhang M. Hydroxysafflor yellow A protects against ulcerative colitis via suppressing TLR4/NF-κB signaling pathway. Chem Biol Drug Des 2022;99:897-907. [PMID: 35319164 DOI: 10.1111/cbdd.14045] [Reference Citation Analysis]
16 Qu L, Lin X, Liu C, Ke C, Zhou Z, Xu K, Cao G, Liu Y. Atractylodin Attenuates Dextran Sulfate Sodium-Induced Colitis by Alleviating Gut Microbiota Dysbiosis and Inhibiting Inflammatory Response Through the MAPK Pathway. Front Pharmacol 2021;12:665376. [PMID: 34335244 DOI: 10.3389/fphar.2021.665376] [Cited by in F6Publishing: 1] [Reference Citation Analysis]